Oruka Therapeutics, Inc. ORKA Non Refundable License Fee
Non Refundable License Fee at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept orka:NonRefundableLicenseFee.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s non refundable license fee.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s non refundable license fee?
- Oruka Therapeutics, Inc. (ORKA) reported non refundable license fee of $150K in Q4 2024.
- What does non refundable license fee mean?
- Represents one-time or milestone-based payments made to third parties to secure intellectual property or technology rights that are not subject to reimbursement. These fees are critical for biotech companies building their pipeline through external partnerships. High levels of these fees indicate an active strategy of in-licensing external innovation.